THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders including multiple sclerosis (MS) and neuromyelitis optica (NMO), is pleased to announce that Dr. Jason Kralic has joined the company in the new role of Vice President of Business Development. Dr. Kralic will be responsible for business development activities, including partnering, licensing and managing external relationships, and he will report directly to Neil Warma, President and CEO of Opexa.
Help employers find you! Check out all the jobs and post your resume.
